Akebia Therapeutics Announces Poster Presentation at ASN Kidney Week 2022

Rhea-AI Summary

Akebia Therapeutics, Inc. (Nasdaq: AKBA) announced its participation in ASN Kidney Week 2022, taking place from November 3-6 in Orlando. The company will present a poster titled "Prevalence of Hyporesponse to Erythropoiesis-Stimulating Agents Among Medicare Patients with CKD-Related Anemia" on November 3 from 10:00 a.m. to 12:00 p.m. EDT. Attendees can visit Akebia at Booth #1721 for more information. Founded in 2007 and based in Cambridge, Massachusetts, Akebia focuses on developing therapeutics for kidney disease.

Positive

• Participation in ASN Kidney Week 2022 can enhance visibility among healthcare professionals.
• Opportunity to present research data that may provide valuable insights into kidney disease treatment.

Negative

• None.

CAMBRIDGE, Mass., Oct. 21, 2022 /PRNewswire/ -- Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that it will present data at the American Society of Nephrology Kidney Week 2022 (ASN Kidney Week 2022), which will take place in Orlando, November 3-6, 2022.  

The poster titled, "Prevalence of Hyporesponse to Erythropoiesis-Stimulating Agents Among Medicare Patients with CKD-Related Anemia According to Absolute or Weight-Based Definitions," poster number TH-PO666, will be presented during the Anemia and Iron Metabolism session on Thursday, November 3 from 10:00 a.m. to 12:00 p.m. EDT. View the abstract here: https://www.asn-online.org/education/kidneyweek/2022/program-abstract.aspx?controlId=3769598.  

ASN Kidney Week 2022 attendees can visit the Akebia Booth #1721.  

About Akebia Therapeutics 
Akebia Therapeutics, Inc. is a fully integrated biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease. Akebia was founded in 2007 and is headquartered in Cambridge, Massachusetts. For more information, please visit our website at www.akebia.com, which does not form a part of this release.

Akebia Therapeutics Contact 
Mercedes Carrasco
mcarrasco@akebia.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/akebia-therapeutics-announces-poster-presentation-at-asn-kidney-week-2022-301655111.html

SOURCE Akebia Therapeutics

FAQ

What will Akebia present at ASN Kidney Week 2022?

Akebia will present a poster on the prevalence of hyporesponse to erythropoiesis-stimulating agents among Medicare patients with CKD-related anemia.

When is Akebia's presentation at ASN Kidney Week 2022?

The presentation is scheduled for November 3, 2022, from 10:00 a.m. to 12:00 p.m. EDT.

Where can I find Akebia at ASN Kidney Week 2022?

You can visit Akebia at Booth #1721 during the event.

What is the significance of Akebia's participation in ASN Kidney Week 2022?

Participation offers Akebia an opportunity to engage with healthcare professionals and showcase their research in kidney disease.